Cyclin A in cell cycle control and cancer CH Yam, TK Fung, RYC Poon Cellular and Molecular Life Sciences CMLS 59, 1317-1326, 2002 | 615 | 2002 |
The cdc2‐related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. RY Poon, K Yamashita, JP Adamczewski, T Hunt, J Shuttleworth The EMBO Journal 12 (8), 3123-3132, 1993 | 519 | 1993 |
Cyclin-dependent kinases and S phase control in mammalian cells RA Woo, RYC Poon Cell cycle 2 (4), 315-323, 2003 | 314 | 2003 |
On the synthesis and destruction of A-and B-type cyclins during oogenesis and meiotic maturation in Xenopus laevis. H Kobayashi, J Minshull, C Ford, R Golsteyn, R Poon, T Hunt The Journal of Cell Biology 114 (4), 755-765, 1991 | 298 | 1991 |
Identification of the domains in cyclin A required for binding to, and activation of, p34cdc2 and p32cdk2 protein kinase subunits. H Kobayashi, E Stewart, R Poon, JP Adamczewski, J Gannon, T Hunt Molecular Biology of the Cell 3 (11), 1279-1294, 1992 | 297 | 1992 |
Redistribution of the CDK inhibitor p27 between different cyclin. CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. RY Poon, H Toyoshima, T Hunter Molecular Biology of the Cell 6 (9), 1197-1213, 1995 | 293 | 1995 |
A roller coaster ride with the mitotic cyclins TK Fung, RYC Poon Seminars in cell & developmental biology 16 (3), 335-342, 2005 | 254 | 2005 |
Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin RYC Poon, T Hunter Science 270 (5233), 90-93, 1995 | 244 | 1995 |
Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver JH Albrecht, RYC Poon, CL Ahonen, BM Rieland, C Deng, GS Crary Oncogene 16 (16), 2141-2150, 1998 | 229 | 1998 |
Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage RYC Poon, W Jiang, H Toyoshima, T Hunter Journal of Biological Chemistry 271 (22), 13283-13291, 1996 | 218 | 1996 |
How many mutant p53 molecules are needed to inactivate a tetramer? WM Chan, WY Siu, A Lau, RYC Poon Molecular and cellular biology 24 (8), 3536-3551, 2004 | 215 | 2004 |
Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells A Mal, RYC Poon, PH Howe, H Toyoshima, T Hunter, ML Harter Nature 380 (6571), 262-265, 1996 | 187 | 1996 |
The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells RYC Poon, MS Chau, K Yamashita, T Hunter Cancer Research 57 (22), 5168-5178, 1997 | 162 | 1997 |
MDM2 and MDMX bind and stabilize the p53-related protein p73 WM Ongkeko, XQ Wang, WY Siu, AWS Lau, K Yamashita, AL Harris, ... Current biology 9 (15), 829-832, 1999 | 159 | 1999 |
Identification of functional domains in the neuronal Cdk5 activator protein RYC Poon, J Lew, T Hunter Journal of Biological Chemistry 272 (9), 5703-5708, 1997 | 148 | 1997 |
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation RA Woo, RYC Poon Genes & development 18 (11), 1317-1330, 2004 | 146 | 2004 |
The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability Y Chen, RYC Poon Frontiers in Bioscience-Landmark 13 (13), 5016-5029, 2008 | 138 | 2008 |
The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2 KM Leung, LS Po, FC Tsang, WY Siu, A Lau, HTB Ho, RYC Poon Cancer research 62 (17), 4890-4893, 2002 | 137 | 2002 |
Cdc37: a protein kinase chaperone? T Hunter, RYC Poon Trends in cell biology 7 (4), 157-161, 1997 | 133 | 1997 |
Specialized roles of the two mitotic cyclins in somatic cells: Cyclin A as an activator of M phase–promoting factor TK Fung, HT Ma, RYC Poon Molecular biology of the cell 18 (5), 1861-1873, 2007 | 132 | 2007 |